Progenics Pharmaceuticals (PGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,612 | -44,672 | -43,688 | -21,618 | -69,429 |
| Depreciation Amortization | 5,967 | 5,569 | 2,582 | 1,544 | 3,896 |
| Accounts receivable | -6,185 | 658 | -296 | 1,588 | -2,175 |
| Other Working Capital | -38,247 | -3,338 | -13,251 | -15,069 | 73,121 |
| Other Operating Activity | 19,268 | 13,478 | 15,602 | 24,398 | 5,989 |
| Operating Cash Flow | $-49,809 | $-28,305 | $-39,051 | $-9,157 | $11,402 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 80,233 | 72,496 | -22,198 | -31,141 | -80,365 |
| PPE Investments | -901 | -2,172 | -5,151 | -8,768 | -1,212 |
| Net Acquisitions | N/A | N/A | N/A | -13,128 | N/A |
| Other Investing Activity | 320 | 32 | -8 | -6 | -3 |
| Investing Cash Flow | $79,652 | $70,356 | $-27,357 | $-53,043 | $-81,580 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,874 | 6,453 | 68,015 | 7,075 | 136,791 |
| Common Stock Repurchased | N/A | -2,741 | -19 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -3,112 | 0 | -4,768 |
| Financing Cash Flow | $4,874 | $3,712 | $64,884 | $7,075 | $132,023 |
| Beginning Cash Position | 56,186 | 10,423 | 11,947 | 67,072 | 5,227 |
| End Cash Position | 90,903 | 56,186 | 10,423 | 11,947 | 67,072 |
| Net Cash Flow | $34,717 | $45,763 | $-1,524 | $-55,125 | $61,845 |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,809 | -28,305 | -39,051 | -9,157 | 11,402 |
| Capital Expenditure | -901 | -2,172 | -5,151 | -8,768 | -1,212 |
| Free Cash Flow | -50,710 | -30,477 | -44,202 | -17,925 | 10,190 |